| RS1596682330 |
ATP2A1
|
Health Risk |
Likely pathogenic |
Brody myopathy, Brody myopathy |
| RS1596687174 |
ABCC6
|
Health Risk |
Pathogenic |
Autosomal recessive inherited pseudoxanthoma elasticum, Autosomal recessive inherited pseudoxanthoma elasticum |
| RS1596687555 |
PHKG2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXc, Glycogen storage disease IXc |
| RS1596711175 |
MAPK8IP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with or without variable brain abnormalities, NEDBA |
| RS1596712783 |
CD19
|
Health Risk |
Likely pathogenic |
Inherited Immunodeficiency Diseases, Inherited Immunodeficiency Diseases |
| RS1596712899 |
MYH11
|
Health Risk |
Pathogenic/Likely pathogenic |
Aortic aneurysm, familial thoracic 4 |
| RS1596714308 |
STX1B
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 9 |
| RS1596714579 |
STX1B
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 9 |
| RS1596714750 |
STX1B
|
Health Risk |
Pathogenic |
— |
| RS1596716834 |
STX1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy with febrile seizures plus, type 9 |
| RS1596716888 |
STX1B
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 9 |
| RS1596717264 |
STX1B
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 9 |
| RS1596718225 |
CD19
|
Health Risk |
Likely pathogenic |
Immunodeficiency, common variable |
| RS1596719437 |
STX1B
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 9 |
| RS1596730121 |
MYH11
|
Health Risk |
Likely pathogenic |
— |
| RS1596759273 |
ZNF423
|
Health Risk |
Likely pathogenic |
Nephronophthisis 14, ZNF423-related disorder |
| RS1596760831 |
SCNN1G
|
Health Risk |
Likely pathogenic |
Bronchiectasis with or without elevated sweat chloride 3, Liddle syndrome 2 |
| RS1596763347 |
ZNF423
|
Health Risk |
Pathogenic |
Joubert syndrome 19, Joubert syndrome 19 |
| RS1596763358 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 4 |
| RS1596766963 |
MAPK8IP3
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without variable brain abnormalities, NEDBA |
| RS1596772428 |
CERS3
|
Health Risk |
Likely pathogenic |
Autosomal recessive congenital ichthyosis 9, Autosomal recessive congenital ichthyosis 9 |
| RS1596777509 |
SCNN1G
|
Health Risk |
Likely pathogenic |
— |
| RS1596779402 |
SCNN1G
|
Health Risk |
Pathogenic |
Pseudohypoaldosteronism, type IB3 |
| RS1596779433 |
SCNN1G
|
Health Risk |
Pathogenic |
Pseudohypoaldosteronism, type IB3 |
| RS1596779485 |
SCNN1G
|
Health Risk |
Likely pathogenic |
— |
| RS1596780112 |
MAPK8IP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with or without variable brain abnormalities, NEDBA |
| RS1596783639 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596784178 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS1596784310 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596784713 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596785514 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596786167 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS1596786219 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596786512 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596786752 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596787407 |
CREBBP
|
Health Risk |
Pathogenic |
— |
| RS1596787459 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596787821 |
GNAO1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 17 |
| RS1596788162 |
CREBBP
|
Health Risk |
Likely pathogenic |
— |
| RS1596791996 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1 |
| RS1596793242 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, CREBBP-related disorder |
| RS1596803811 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596804073 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596804126 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596805575 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS1596805792 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596805807 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596805927 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596810419 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596810435 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596810465 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596812202 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596812256 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596812290 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596812306 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596812454 |
PARN
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 6 |
| RS1596813570 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596813665 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596823180 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596834998 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596839714 |
CREBBP
|
Health Risk |
Pathogenic/Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome |
| RS1596839727 |
CREBBP
|
Health Risk |
Pathogenic |
— |
| RS1596842934 |
ABCA3
|
Health Risk |
Likely pathogenic |
Primary interstitial lung disease specific to childhood due to pulmonary surfactant protein anomalies, Hereditary pulmonary alveolar proteinosis |
| RS1596848231 |
PARN
|
Health Risk |
Likely pathogenic |
Familial Interstitial Pneumonia, Pulmonary fibrosis |
| RS1596852443 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596852463 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596852578 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Inborn genetic diseases |
| RS1596852670 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome |
| RS1596852674 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596852902 |
TBX6
|
Health Risk |
Pathogenic |
Scoliosis, Scoliosis |
| RS1596853067 |
TBX6
|
Health Risk |
Likely pathogenic |
Scoliosis, Scoliosis |
| RS1596853085 |
TBX6
|
Health Risk |
Pathogenic |
Scoliosis, Scoliosis |
| RS1596853925 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596854023 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596854369 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596854441 |
KIF22
|
Health Risk |
Likely pathogenic |
Spondyloepimetaphyseal dysplasia with multiple dislocations, Spondyloepimetaphyseal dysplasia with multiple dislocations |
| RS1596856176 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596856285 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596856390 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596861969 |
NUP93
|
Health Risk |
Likely pathogenic |
Focal segmental glomerulosclerosis, Focal segmental glomerulosclerosis |
| RS1596864597 |
GPT2
|
Health Risk |
Likely pathogenic |
Glutamate pyruvate transaminase 2 deficiency, Glutamate pyruvate transaminase 2 deficiency |
| RS1596867702 |
GNAO1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 17 |
| RS1596871452 |
GNAO1
|
Health Risk |
Likely pathogenic |
Dyskinesia, Chorea |
| RS1596872804 |
GNAO1
|
Health Risk |
Pathogenic |
Choreoathetosis, Inborn genetic diseases |
| RS1596878700 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596878921 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596882004 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596882010 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596882124 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596882629 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596883431 |
SLC12A3
|
Health Risk |
Pathogenic |
Familial hypokalemia-hypomagnesemia, Familial hypokalemia-hypomagnesemia |
| RS1596885651 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596885894 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596886048 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596886086 |
SLC12A3
|
Health Risk |
Likely pathogenic |
Familial hypokalemia-hypomagnesemia, Familial hypokalemia-hypomagnesemia |
| RS1596886132 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596886183 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS1596886295 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1596889984 |
PRRT2
|
Health Risk |
Pathogenic |
Episodic kinesigenic dyskinesia, Episodic kinesigenic dyskinesia |
| RS1596890176 |
SLC12A3
|
Health Risk |
Likely pathogenic |
Familial hypokalemia-hypomagnesemia, Familial hypokalemia-hypomagnesemia |